KINDRED BIOSCIENCES, INC.

(KIN)
Cours en clôture Nasdaq  -  27/08
9.250 USD   +0.11%
01/02Obseva nomme une responsable de la stratégie
AW
01/02ObsEva nomme un directeur de la stratégie
MT
2021KINDRED BIOSCIENCES, INC. : Stifel Nicolaus n'est plus acheteur
ZM
SynthèseCotationsGraphiquesActualitésNotationsSociétéFonds 


Aucune donnée



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique KINDRED BIOSCIENCES, INC.
Durée : Période :
Kindred Biosciences, Inc. : Graphique analyse technique Kindred Biosciences, Inc. | Zone bourse
Graphique plein écran
Secteur et Concurrence
Var. 1janvCapi. (M$)
KINDRED BIOSCIENCES, INC.0.00%421
GILEAD SCIENCES, INC.-14.10%78 232
REGENERON PHARMACEUTICALS, INC.2.22%69 552
VERTEX PHARMACEUTICALS12.35%63 100
WUXI APPTEC CO., LTD.-14.92%43 023
BIONTECH SE-38.39%38 601